Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Baxter Healthcare Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (313)
Cancellation by sponsor (104)
Section 14, TGO91 consent (19)
Australian Public Assessment Report (AusPAR) (8)
Prescription medicine registration (8)
Cancellation for failure to pay annual charge (2)

Date

2026 (4)
2025 (19)
2024 (10)
2023 (19)
2022 (24)
2021 (24)
2020 (34)
2019 (30)
2018 (22)
2017 (8)
2016 (24)
2015 (20)
2014 (16)
2013 (14)
2012 (5)
2011 (18)
2010 (16)
2009 (14)
2008 (8)
2007 (29)
2005 (5)
2004 (3)
2003 (1)
2002 (5)
2001 (5)
1998 (1)
1997 (2)
1996 (5)
1994 (17)
1993 (5)
1991 (47)

Search

Sponsor content

454 result(s) found, displaying 171 to 180

Baxter Healthcare Pty Ltd - Warmer, blood/solution Cancelled under Section 41GL(d) of the Act

10 September 2019

Cancellation by sponsor

Requested by Baxter Healthcare Pty Ltd
Baxter Healthcare Pty Ltd - Citric acid haemodialysis system cleaning cartridge Cancelled under Section 41GL(d) of the Act

10 September 2019

Cancellation by sponsor

Requested by Baxter Healthcare Pty Ltd
Baxter Healthcare Pty Ltd - Syringe tip cap Cancelled under Section 41GL(d) of the Act

10 September 2019

Cancellation by sponsor

Requested by Baxter Healthcare Pty Ltd
MOXIFLOXACIN-BAXTER moxifloxacin (as hydrochloride) 400 mg/250 mL solution for intravenous infusion bottle (260842)

30 August 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MOXIFLOXACIN-BAXTER moxifloxacin (as hydrochloride) 400 mg/250 mL solution for intravenous infusion bottle.
Baxter Healthcare Pty Ltd - Test instrument, dialysis Cancelled under Section 41GL(d) of the Act

28 June 2019

Cancellation by sponsor

Requested by Baxter Healthcare Pty Ltd
Baxter Healthcare Pty Ltd - Test instrument, dialysis Cancelled under Section 41GL(d) of the Act

28 June 2019

Cancellation by sponsor

Requested by Baxter Healthcare Pty Ltd
Baxter Healthcare Pty Ltd - ActualWay Therapy Chair - Chair, examination/treatment, electric Cancelled under Section 41GL(d) of the Act

28 June 2019

Cancellation by sponsor

Requested by Baxter Healthcare Pty Ltd
Baxter Healthcare Pty Ltd - Warmer, blood/solution Cancelled under Section 41GL(d) of the Act

28 June 2019

Cancellation by sponsor

Requested by Baxter Healthcare Pty Ltd
Baxter Healthcare Pty Ltd - Dialysate, haemodialysis Cancelled under Section 41GL(d) of the Act

28 June 2019

Cancellation by sponsor

Requested by Baxter Healthcare Pty Ltd
Baxter Healthcare Pty Ltd - Dialysis start/stop set Cancelled under Section 41GL(d) of the Act

28 June 2019

Cancellation by sponsor

Requested by Baxter Healthcare Pty Ltd

Pages

First page
Previous page
…
Page 14
Page 15
Page 16
Page 17
Current page 18
Page 19
Page 20
Page 21
Page 22
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.